Active ingredient
Morphine
155 finished FDA listings contain Morphine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- MORPHINE, MORPHINE SULFATE
- Dosage forms
- Capsule, Extended Release, Injection, Injection, Solution, Solution, Suppository, Tablet, Tablet, Extended Release, Tablet, Film Coated, Extended Release, Tincture
- Routes
- Epidural, Intramuscular, Intrathecal, Intravenous, Oral, Rectal
- Manufacturers / labelers
- 30
- Strengths listed
- .5 mg/ml · 1 g/100ml · 1 mg/.5ml · 1 mg/30ml · 1 mg/ml · 10 g/1000ml · 10 mg/1 · 10 mg/5ml · 10 mg/ml · 100 mg/1 · 100 mg/5ml · 120 mg/1 · 15 mg/1 · 2 mg/ml · 20 mg/1 · 20 mg/5ml · 20 mg/ml · 200 mg/1 · 200 mg/20ml · 25 mg/ml · 30 mg/1 · 4 mg/ml · 40 mg/1 · 45 mg/1 · 5 mg/1 · 5 mg/ml · 50 mg/1 · 50 mg/ml · 500 mg/20ml · 60 mg/1 · 75 mg/1 · 8 mg/ml · 80 mg/1 · 90 mg/1
- Brand names in FDA listings
- Duramorph, Infumorph 200, Infumorph 500, Mitigo, Morphine Sulfate Er, Morphine Sulfate Extended Release, Ms Contin, Opium, Opium Tincture Deodorized
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 7052
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 018565 | HIKMA | 1984-09-18 | 4 |
| NDA 019516 | KNOA PHARMA | 1987-05-29 | 3 |
| ANDA 073510 | HOSPIRA | 1992-09-30 | 1 |
| ANDA 073509 | HOSPIRA | 1992-09-30 | 1 |
| ANDA 074769 | RHODES PHARMS | 1998-07-02 | 5 |
| ANDA 074862 | RHODES PHARMS | 1998-07-07 | 10 |
| ANDA 076438 | SPECGX LLC | 2003-07-03 | 2 |
| ANDA 076412 | SPECGX LLC | 2003-07-31 | 3 |
| NDA 022207 | HIKMA | 2008-03-17 | 2 |
| NDA 022195 | HIKMA | 2008-03-17 | 11 |
| ANDA 202348 | SPECGX LLC | 2011-07-15 | 1 |
| NDA 202515 | HOSPIRA INC | 2011-11-14 | 5 |
| ANDA 078761 | SUN PHARM INDS LTD | 2012-05-11 | 18 |
| ANDA 079040 | ACTAVIS ELIZABETH | 2013-01-16 | 6 |
| ANDA 202104 | UPSHER SMITH LABS | 2013-06-03 | 7 |
| NDA 204223 | FRESENIUS KABI USA | 2013-10-30 | 11 |
| ANDA 203518 | TRIS PHARMA INC | 2015-05-12 | 9 |
| ANDA 205758 | HIKMA | 2015-05-21 | 4 |
| ANDA 203602 | NOVEL LABS INC | 2015-12-16 | 5 |
| ANDA 200411 | IMPAX LABS INC | 2016-04-12 | 7 |
| ANDA 206573 | PHARM ASSOC | 2016-11-14 | 2 |
| ANDA 204393 | PIRAMAL CRITICAL | 2018-07-16 | 2 |
| ANDA 210610 | UPSHER SMITH LABS | 2019-07-22 | 2 |
| ANDA 212451 | ALKEM LABS LTD | 2020-12-03 | 6 |
| ANDA 211454 | WINDER LABS LLC | 2021-02-12 | 3 |
| ANDA 202861 | INTL MEDICATION SYS | 2021-04-29 | 1 |
| ANDA 203158 | ANDA REPOSITORY | 2021-08-04 | 6 |
| ANDA 211452 | HIKMA | 2023-01-12 | 2 |
| ANDA 215194 | SPECGX LLC | 2023-08-21 | 4 |
Official labeling on DailyMed
- MORPHINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI, USA LLC] · version 8 · 2026-09-10
- MORPHINE SULFATE TABLET, EXTENDED RELEASE [SPECGX LLC] · version 39 · 2026-09-07
- MORPHINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] · version 7 · 2026-09-02
- MORPHINE SULFATE SOLUTION [PRECISION DOSE, INC.] · version 4 · 2026-08-31
- MORPHINE SULFATE SOLUTION [PRECISION DOSE, INC.] · version 4 · 2026-08-28
- MORPHINE SULFATE SOLUTION [PRECISION DOSE, INC.] · version 4 · 2026-08-28
- MORPHINE SULFATE SOLUTION [PRECISION DOSE, INC.] · version 3 · 2026-08-28
- MORPHINE SULFATE SOLUTION [PRECISION DOSE, INC.] · version 6 · 2026-08-28
- MORPHINE SULFATE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 7 · 2026-08-24
- MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [RHODES PHARMACEUTICALS LLC] · version 18 · 2026-08-19
- MORPHINE SULFATE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 13 · 2026-08-14
- MORPHINE SULFATE SOLUTION [AMERICAN HEALTH PACKAGING] · version 1 · 2026-08-10
Showing the 12 most recent of 77 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.